MEIRAGTX HOLDINGS PLC (MGTX) Fundamental Analysis & Valuation
NASDAQ:MGTX • KYG596651029
Current stock price
7.62 USD
+0.09 (+1.2%)
At close:
7.62 USD
0 (0%)
After Hours:
This MGTX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. MGTX Profitability Analysis
1.1 Basic Checks
- In the past year MGTX has reported negative net income.
- In the past year MGTX has reported a negative cash flow from operations.
- In the past 5 years MGTX always reported negative net income.
- MGTX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of MGTX (-89.03%) is worse than 71.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -89.03% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-40.41%
ROA(5y)-32.41%
ROE(3y)-129.61%
ROE(5y)-91.21%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- MGTX has a Gross Margin of 41.01%. This is in the better half of the industry: MGTX outperforms 73.60% of its industry peers.
- MGTX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. MGTX Health Analysis
2.1 Basic Checks
- MGTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- MGTX has more shares outstanding than it did 1 year ago.
- MGTX has more shares outstanding than it did 5 years ago.
- MGTX has a worse debt/assets ratio than last year.
2.2 Solvency
- MGTX has an Altman-Z score of -8.01. This is a bad value and indicates that MGTX is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of MGTX (-8.01) is worse than 69.17% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -8.01 |
ROIC/WACCN/A
WACC10.18%
2.3 Liquidity
- MGTX has a Current Ratio of 0.22. This is a bad value and indicates that MGTX is not financially healthy enough and could expect problems in meeting its short term obligations.
- MGTX has a worse Current ratio (0.22) than 92.10% of its industry peers.
- A Quick Ratio of 0.22 indicates that MGTX may have some problems paying its short term obligations.
- MGTX's Quick ratio of 0.22 is on the low side compared to the rest of the industry. MGTX is outperformed by 92.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.22 | ||
| Quick Ratio | 0.22 |
3. MGTX Growth Analysis
3.1 Past
- The earnings per share for MGTX have decreased by -2.93% in the last year.
- Looking at the last year, MGTX shows a very strong growth in Revenue. The Revenue has grown by 96.83%.
- Measured over the past years, MGTX shows a very strong growth in Revenue. The Revenue has been growing by 20.15% on average per year.
EPS 1Y (TTM)-2.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.73%
Revenue 1Y (TTM)96.83%
Revenue growth 3Y-4.07%
Revenue growth 5Y20.15%
Sales Q2Q%-96.24%
3.2 Future
- MGTX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.15% yearly.
- MGTX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 90.67% yearly.
EPS Next Y-3.92%
EPS Next 2Y17.64%
EPS Next 3Y16.32%
EPS Next 5Y14.15%
Revenue Next Year94.29%
Revenue Next 2Y260.66%
Revenue Next 3Y118.38%
Revenue Next 5Y90.67%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. MGTX Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for MGTX. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MGTX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as MGTX's earnings are expected to grow with 16.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.64%
EPS Next 3Y16.32%
5. MGTX Dividend Analysis
5.1 Amount
- No dividends for MGTX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
MGTX Fundamentals: All Metrics, Ratios and Statistics
7.62
+0.09 (+1.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-12 2026-03-12/amc
Earnings (Next)05-11 2026-05-11
Inst Owners53.45%
Inst Owner Change0.71%
Ins Owners4.84%
Ins Owner Change10.94%
Market Cap613.33M
Revenue(TTM)27.42M
Net Income(TTM)-168.69M
Analysts84.29
Price Target28.27 (271%)
Short Float %9.5%
Short Ratio12.94
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.36%
Min EPS beat(2)-24.05%
Max EPS beat(2)-0.66%
EPS beat(4)1
Avg EPS beat(4)-3.75%
Min EPS beat(4)-24.05%
Max EPS beat(4)12.47%
EPS beat(8)2
Avg EPS beat(8)-41.18%
EPS beat(12)4
Avg EPS beat(12)-30.49%
EPS beat(16)5
Avg EPS beat(16)-24.85%
Revenue beat(2)0
Avg Revenue beat(2)-74.5%
Min Revenue beat(2)-94.22%
Max Revenue beat(2)-54.78%
Revenue beat(4)1
Avg Revenue beat(4)272.91%
Min Revenue beat(4)-94.22%
Max Revenue beat(4)1298.04%
Revenue beat(8)2
Avg Revenue beat(8)173.75%
Revenue beat(12)3
Avg Revenue beat(12)102.95%
Revenue beat(16)6
Avg Revenue beat(16)103.42%
PT rev (1m)1.24%
PT rev (3m)0.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)17.87%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 22.37 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.11
EYN/A
EPS(NY)-1.31
Fwd EYN/A
FCF(TTM)-1.5
FCFYN/A
OCF(TTM)-1.44
OCFYN/A
SpS0.34
BVpS-0.5
TBVpS-0.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -89.03% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.01% | ||
| FCFM | N/A |
ROA(3y)-40.41%
ROA(5y)-32.41%
ROE(3y)-129.61%
ROE(5y)-91.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 38.18% | ||
| Cap/Sales | 17.41% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.22 | ||
| Quick Ratio | 0.22 | ||
| Altman-Z | -8.01 |
F-Score4
WACC10.18%
ROIC/WACCN/A
Cap/Depr(3y)233.72%
Cap/Depr(5y)368.57%
Cap/Sales(3y)147.08%
Cap/Sales(5y)142.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.73%
EPS Next Y-3.92%
EPS Next 2Y17.64%
EPS Next 3Y16.32%
EPS Next 5Y14.15%
Revenue 1Y (TTM)96.83%
Revenue growth 3Y-4.07%
Revenue growth 5Y20.15%
Sales Q2Q%-96.24%
Revenue Next Year94.29%
Revenue Next 2Y260.66%
Revenue Next 3Y118.38%
Revenue Next 5Y90.67%
EBIT growth 1Y7.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.57%
OCF growth 3YN/A
OCF growth 5YN/A
MEIRAGTX HOLDINGS PLC / MGTX Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for MEIRAGTX HOLDINGS PLC?
ChartMill assigns a fundamental rating of 2 / 10 to MGTX.
What is the valuation status for MGTX stock?
ChartMill assigns a valuation rating of 0 / 10 to MEIRAGTX HOLDINGS PLC (MGTX). This can be considered as Overvalued.
Can you provide the profitability details for MEIRAGTX HOLDINGS PLC?
MEIRAGTX HOLDINGS PLC (MGTX) has a profitability rating of 1 / 10.
Can you provide the financial health for MGTX stock?
The financial health rating of MEIRAGTX HOLDINGS PLC (MGTX) is 0 / 10.